enVVeno Medical Corp reports results for the quarter ended in March - Earnings Summary

enVVeno Medical

11/05/2024 01:03

* enVVeno Medical Corp  NVNO.OQ  reported a quarterly
adjusted
loss of 31 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -57 cents.  The lone analyst forecast for the
quarter was for a loss of 40 cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * enVVeno Medical Corp's reported EPS for the quarter was a
loss
of 31 cents​.
    * The company reported a quarterly loss of $4.99 million.
    * enVVeno Medical Corp shares had fallen by 8.6% this
quarter and
lost 3.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 4.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for enVVeno Medical
Corp is $20.40 
This summary was machine generated from LSEG data May 11 at
12:02 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.40          -0.31          Beat
 Sep. 30 2023      -0.46          -0.36          Beat
 Sep. 30 2023      -0.48          -0.45          Beat
 Jun. 30 2023      -0.49          -0.58          Missed